ARTY
Live / Registered — Registered (as of 19 Sept 2023)
What this means for you
Registered since 19 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90572029
- Registration number
- 7166648
- Mark type
- Stylized text
- Filed
- 10 Mar 2021
- Published for opposition
- 25 Apr 2023
- Registered
- 19 Sept 2023
- Attorney of record
- ANDREW D. PRICE
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, viral infections, and tumorous diseases; biological preparations for the treatment of viral infections; biological preparations for medical use for the treatment of tumorous diseases; immunotherapeutic drugs, namely, pharmaceutical preparations for the treatment of cancer, viral infections, tumorous diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical diagnostic reagents used in connection with drug discovery, namely, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; medical diagnostic reagents used in connection with protein engineering and biological drug development; all of the foregoing excluding treatment of osteoarticular disorders, of bone and joint pathologies, of musculoskeletal pathologies and of degenerative and chronic inflammatory pathologies, vertebral-spinal pathologies and disorders, degenerative and chronic inflammatory pathologies, inflammatory pathologies due to rheumatic disorders, or trauma or auto-immune conditions
- Class 042 — Scientific and technological services: Scientific and technological services, namely, pharmaceutical research and design relating thereto; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; drug discovery, namely, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; protein engineering and biological drug development; provision of information and consultancy in relation to the aforesaid services; all of the foregoing excluding treatment of osteoarticular disorders, of bone and joint pathologies, of musculoskeletal pathologies and of degenerative and chronic inflammatory pathologies, vertebral-spinal pathologies and disorders, degenerative and chronic inflammatory pathologies, inflammatory pathologies due to rheumatic disorders, or trauma or auto-immune conditions
Owner
- Immunocore Limited, Abingdon, Oxfordshire, GB
- Immunocore Limited, Abingdon, Oxfordshire, GB
- Immunocore Limited, Abingdon, Oxfordshire, GB
Prosecution history
- 20 Nov 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 10 Aug 2023 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 20 Jun 2023 — NOTICE OF ALLOWANCE CANCELLED
- 10 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Jun 2023 — TEAS DELETE 1(B) BASIS RECEIVED
- 20 Jun 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Apr 2023 — PUBLISHED FOR OPPOSITION
- 05 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Mar 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 20 Mar 2023 — EXPARTE APPEAL TERMINATED
- 17 Mar 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 16 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER